회사소개
사업소개
치료기술
특수방사선
면역치료
암종별치료
혈액암
폐암
위암(소화기계통)
간암
대장암
췌장암
전립선암
유방암
난소암 자궁암
기타희귀암(루프스)
최근소식
논문
치료사례
동영상게시판
사진게시판
고객센터
상담문의
자주묻는 질문
최근소식
최근소식
회사소개
사업소개
치료기술
암종별치료
최근소식
고객센터
논문
논문
치료사례
동영상게시판
사진게시판
논문
번호
제목
날짜
371
2025년 Blood: HSP-CAR30 with a high proportion of lesss- differentiated Tcells promotes durable responses in refractory CD30+ lymphoma
2025년 Blood: HSP-CAR30 with a high proportion of lesss- differentiated Tcells promotes durable responses in refractory CD30+ lymphoma
2025-06-17
370
2025년 Nature Nanotechnology:A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer
2025년 Nature Nanotechnology:A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer
2025-06-16
369
2025년 Nature Cancer:Lena Gamboa et al, Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigens
2025년 Nature Cancer:Lena Gamboa et al, Sensitizing solid tumors to CAR-mediated cytotoxicity by lipid nanoparticle delivery of synthetic antigens
2025-06-16
368
2025년 Cell: Immunotherapy-related cognitive impairment after CAR T cell therapy in mice
2025년 Cell: Immunotherapy-related cognitive impairment after CAR T cell therapy in mice
2025-06-16
367
2025년 nature cancer: An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
2025년 nature cancer: An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
2025-06-16
366
2025년 Cell Research:Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
2025년 Cell Research:Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
2025-05-18
365
2025년 Cancer Research:Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles
2025년 Cancer Research:Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles
2025-05-18
364
2025년 Cell Metabolism:Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
2025년 Cell Metabolism:Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
2025-05-18
363
2025년 Cell Med:CD19 CAR-T cell therapy in a pediatric patient with MDA5+ dermatomyositis and rapidly progressive interstitial lung disease
2025년 Cell Med:CD19 CAR-T cell therapy in a pediatric patient with MDA5+ dermatomyositis and rapidly progressive interstitial lung disease
2025-05-18
362
2025년 Nature Cancer:An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
2025년 Nature Cancer:An in situ engineered chimeric IL-2 receptor potentiates the tumoricidal activity of proinflammatory CAR macrophages in renal cell carcinoma
2025-05-18
제목
내용
제목+내용
검색
처음
1
페이지
2
페이지
열린
3
페이지
4
페이지
5
페이지
6
페이지
7
페이지
8
페이지
9
페이지
10
페이지
다음
맨끝